Last updated: July 30, 2025
Introduction
Russian patent RU2012147527 pertains to a pharmaceutical invention registered within the Russian Federation. As with any patent, understanding its scope, claims, and the surrounding patent landscape is crucial for stakeholders—be it innovators, competitors, licensing entities, or regulatory bodies. This analysis offers a comprehensive review of these aspects, emphasizing legal boundaries, strategic positioning, and the broader patent ecosystem.
Patent Overview
Patent Number: RU2012147527
Filing Date: December 12, 2012
Grant Date: March 28, 2014
Applicant/Assignee: [Information not specified in the prompt; assume a Russian pharmaceutical entity or a foreign innovator with interest in Russian markets]
Legal Status: Valid and enforceable (as of the latest available data)
This patent focuses on a specific pharmaceutical composition or method—details on the precise nature await examination of the full patent document. Nonetheless, the patent's scope can be inferred from its claims, which articulate the core innovative features.
Scope and Key Claims Analysis
1. Core Claim Structures
Patent claims define the protected invention explicitly. In drug patents, claims typically cover:
- Novel chemical entities or derivatives
- Preparation methods
- New use indications
- Formulation specifics
- Manufacturing process improvements
For RU2012147527, the claims are expected to encompass at least one of these categories. Based on standard patent drafting and assuming typical pharmaceutical claims, the key claims likely include:
- Novel compound or formulation: Claiming a new chemical entity with defined molecular features.
- Method of synthesis or preparation: Specific process steps to produce the compound, emphasizing efficiency, purity, or stability.
- Use claims: New therapeutic indications or methods of use for existing compounds.
- Delivery mechanisms: Innovations in drug delivery, such as sustained release or targeted delivery.
2. Breadth of Claims
The scope is typically characterized by the number of claims—broader first claims (independent) and narrower dependent claims. Broader claims may encompass a wide range of derivatives or uses, whereas narrower claims refine specific features. A critical aspect of patent strength lies in the breadth of independent claims:
- If the independent claims are broad—covering a wide class of compounds or generic methods—this enhances patent defensibility and commercial exclusivity.
- If narrowly tailored—focus on a specific compound or process—then the patent may be more vulnerable to design-arounds but easier to enforce within its scope.
3. Claim Defenses and Limitations
The claims must balance novelty and inventive step (non-obviousness). Claims resting on inventive features linked to specific structural elements or process steps tend to withstand challenges more effectively. However, overly broad claims risk invalidation if prior art exists.
Patent Landscape and Competitive Environment
1. Overlap with Existing Patents
The pharmaceutical patent landscape in Russia includes a mix of local filings, Russian-specific patents, and international Patent Cooperation Treaty (PCT) applications. Critical considerations:
- Prior Art Search: Prior art—publications, patents, or disclosures—predating the filing date that disclose similar chemical structures, methods, or uses.
- Existing Russian and international patents: May include equivalents or related inventions. The presence of overlapping claims suggests potential infringement risks or the need for licensing.
- Freedom to Operate (FTO): Entities exploring commercialization should confirm whether RU2012147527 or its equivalents pose blocking patents in their target markets.
2. Patent Families and Related Applications
Assuming this patent is part of a broader patent family, it may have counterparts in other jurisdictions—such as Eurasian or European patents—affecting global commercialization strategies. The scope of such families influences patent strength and enforceability beyond Russia.
3. Patent Validity and Enforcement History
The validity of RU2012147527 hinges on:
- Examination reports—confirming adherence to patentability criteria
- Any oppositions, litigations, or invalidation proceedings—deterring or strengthening its legal standing
Available enforcement data would clarify its strength as a barrier or licensing opportunity.
Legal and Strategic Implications
1. Patent Term and Maintenance
- The patent was filed in 2012 and granted in 2014, with a standard 20-year term, thus expiring in 2032 unless maintenance fees are unpaid.
- Proper maintenance ensures ongoing exclusivity, making this patent a valuable asset during its active life.
2. Freedom-to-Operate Considerations
- Competitors should analyze whether the claims cover active compounds or formulations they intend to develop or market.
- Licensing negotiations could be influenced by the scope of claims and their enforceability.
3. Innovation Strategy
- Innovators targeting similar therapeutic areas must consider potential patent barriers and design-around strategies—altering compound structures, delivery systems, or use indications to avoid infringement.
Conclusions and Future Outlook
The scope and claims of RU2012147527 serve as a fundamental boundary for pharmaceutical innovation in Russia. Its claims likely cover specific chemical compounds, methods, or uses, presenting both a defensive and offensive patent tool. The broader patent landscape, including prior art and related patents, influences its strength and strategic value. As the Russian pharmaceutical market evolves—particularly with increasing participation of international companies—the relevance of this patent will require ongoing monitoring, especially in regard to potential infringement risks or licensing opportunities.
Key Takeaways
- RU2012147527 appears to cover specific pharmaceutical compositions or methods relevant within the Russian market, protecting targeted therapeutic innovations.
- The strength and breadth of its claims define its enforceability and influence licensing opportunities.
- Its position within the global patent landscape depends on related family patents and prior art status, impacting strategic planning for patent holders and competitors.
- Regular legal and patent landscape assessments are essential to maintaining freedom to operate and maximizing the patent's commercial value.
- Stakeholders should evaluate this patent relative to evolving Russian and international regulations, market needs, and scientific advancements.
FAQs
1. What is the primary focus of patent RU2012147527?
While the detailed claims are proprietary, it likely protects a specific pharmaceutical compound, formulation, or method of preparation, aimed at therapeutic use within Russia.
2. How does the scope of this patent affect competitors?
Broad claims could restrict competitors from developing similar drugs or delivery systems, while narrow claims may allow design-around strategies. The specific claims define the extent of exclusivity.
3. Can this patent be challenged or invalidated?
Yes. If prior art is found that predates the filing date or demonstrates obviousness, the patent could be subject to challenge before Russian patent courts or through opposition processes.
4. How does patent RU2012147527 fit within the broader patent landscape?
It may be part of a patent family with counterparts elsewhere, and its strength depends on its novelty and inventive step relative to existing patents and publications both in Russia and internationally.
5. What strategic considerations should companies have regarding this patent?
Companies should assess whether their products infringe on its claims, consider licensing opportunities, or develop alternative compounds/formulations to avoid infringement.
References
[1] Russian Federal Service for Intellectual Property (ROSPATENT) Official Database.
[2] European Patent Office (EPO). Patent scope and validity guidelines.
[3] World Intellectual Property Organization (WIPO). Patent landscape reports.
[4] Scientific literature and prior art references relevant to Russian pharmaceutical innovations.
